We work with experts and partner organisations, including research, policy and industry experts, clinical scientists, product developers, NGOs and funders, to explore global solutions to drug-resistant infections.
To contact the team, email email@example.com.
Head of Drug-resistant Infections Programme
Policy and Advocacy Lead
Science Innovation Lead
The collective overuse of antibiotics has caused one of the most urgent health problems. We want to transform the world's response towards stemming the rise of drug-resistant infections.
This report aims to guide experts, communicators and practitioners to communicate with impact, so that the public understands and supports action on drug-resistant infections.
[Summary] This report aims to help experts and practitioners to communicate with impact, so that the public understands and supports action on drug-resistant infections.
The European Medicines Agencies Network issued a draft strategy document in July 2020, setting out a proposed strategy to guide the work of the European Medicines Agency and Heads of Medicines Agencies for the period 2021-2025 . Wellcome responded to the AMR themeatic questions within this open cons
The Indian Ministry of Environment, Forest and Climate Change issued the draft notification Environment Protection Amendment Rules 2020, setting out proposed national standards for levels of antimicrobials released in pharmaceutical manufacturing effluent. As a potential driver of antimicrobial resi